These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16230301)

  • 1. Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II.
    Antonijevic NM; Milosevic R; Perunicic J; Stanojevic M; Calija B; Vasiljevic Z
    Eur Heart J; 2005 Dec; 26(24):2745-6. PubMed ID: 16230301
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
    Warkentin TE; Cook DJ
    Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin induced thrombocytopenia after low molecular weight heparin treatment: a case report.
    Illuminati G; Caliò FG; Bertagni A; Forte A; Gallinaro L; Montesano G; Ciulli A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):225-8. PubMed ID: 9177626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complication of hip surgery.
    Williams SG; Currie P; Galvani DW
    Postgrad Med J; 2003 May; 79(931):300, 301. PubMed ID: 12782781
    [No Abstract]   [Full Text] [Related]  

  • 6. Endovascular management of acute infrarenal aortic thrombosis caused by heparin-induced thrombocytopenia in a patient treated with low molecular weight heparin.
    Karkos CD; Mandala E; Gerogiannis I; Papadimitriou DN; Gerassimidis TS
    J Vasc Interv Radiol; 2011 Apr; 22(4):581-2. PubMed ID: 21292503
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolytic therapy in acute pulmonary embolism due to heparin-induced thrombocytopenia type II.
    Alafify AA; Al-Khuwaitir TS; Al-Mugheiri AM; Ndao DM
    Saudi Med J; 2005 Nov; 26(11):1800-2. PubMed ID: 16311669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia.
    Bomzer CA
    N Engl J Med; 2001 Aug; 345(8):619; author reply 619-20. PubMed ID: 11529226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low molecular weight heparin in a patient with pulmonary embolism and heparin-induced thrombocytopenia].
    Monreal M; Torrabadella P; Roncales J; Torguet P
    Med Clin (Barc); 1988 Nov; 91(16):638-9. PubMed ID: 2852738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe thrombocytopenia with pulmonary embolism and consumption coagulopathy during treatment with tedelparin].
    Lecompte T; Boiteau R; Richard X; Luo SK; Lecrubier C; Burdin M; Samama M
    Presse Med; 1991 Mar; 20(12):563. PubMed ID: 1851989
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fulminant lung embolism in heparin treatment. Heparin-induced thrombocytopenia type II].
    Stiefelhagen P
    MMW Fortschr Med; 1999 Oct; 141(42):53-4. PubMed ID: 10912108
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin-induced thrombocytopenia: a case of persistent thrombocytopenia].
    Jourdain M; Ennezat PV; Darchis J; Aubert JM; Bauchart JJ; Auffray JL; Asseman P
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):959-62. PubMed ID: 18209698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia (an overview).
    Daneschvar HL; Daw H
    Int J Clin Pract; 2007 Jan; 61(1):130-7. PubMed ID: 16836645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin in pregnancy.
    Kittisupamongkol W
    Am J Obstet Gynecol; 2009 Sep; 201(3):e12; author reply e12. PubMed ID: 19439265
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
    Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
    Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.